Marc-André Gagnon
@m-a-gagnon.bsky.social
1.5K followers
650 following
130 posts
Professor in public policy at Carleton University.
Focus on the political economy of the pharmaceutical sector.
Current research project: https://carleton.ca/ghostmanagement/
Also a big fan of craft beers, slap bass, and Japanese death metal.
Posts
Media
Videos
Starter Packs
Reposted by Marc-André Gagnon
Marc-André Gagnon
@m-a-gagnon.bsky.social
· Aug 22
Universal Pharmacare and Contraceptive Dispensations Among Youth
This time-series analysis study evaluates the association between a publicly funded pharmacare program for individuals younger than 25 years and an increase in prescription contraceptive dispensations...
jamanetwork.com
Marc-André Gagnon
@m-a-gagnon.bsky.social
· Aug 18
Building a Sovereign, Value-Added, and Sustainable Economy - CCPA
U.S. President Donald Trump has confronted Canadians with unprecedented threats to our sovereignty and prosperity. From his inauguration speech, when he resuscitated the imperial doctrine of ‘Manifest...
www.policyalternatives.ca
Reposted by Marc-André Gagnon
Marc-André Gagnon
@m-a-gagnon.bsky.social
· Aug 13
U.S. Batten disease experts who lobbied B.C. to reinstate drug in Charleigh Pollock case had relationships with drug company
U.S. disease experts have consulted for, been paid by, or received grants from California-based BioMarin Pharmaceutical Inc. Find out more.
vancouversun.com
Marc-André Gagnon
@m-a-gagnon.bsky.social
· Jul 29
Health advocates shocked as Carney Liberals back away from pharmacare program
Health advocates say they’re shocked to hear the federal government may not sign more pharmacare funding deals, which would leave coverage uneven across the country.
www.ctvnews.ca
Marc-André Gagnon
@m-a-gagnon.bsky.social
· Jul 24
Canada’s new drug pricing guidelines are industry friendly
The Patented Medicine Prices Review Board’s mandate is to make sure that drug prices are not excessive. However, new guidelines that change criteria for assessing prices may lead to higher prices.
theconversation.com